BioRem Inc. (CVE:BRM – Get Free Report) Director Derek Webb sold 15,000 shares of the company’s stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of C$3.82, for a total value of C$57,300.00. Following the completion of the sale, the director owned 397,370 shares in the company, valued at C$1,517,953.40. The trade was a 3.64% decrease in their position.
BioRem Stock Down 1.6%
BioRem stock opened at C$3.63 on Wednesday. The business’s 50-day moving average price is C$3.32 and its 200 day moving average price is C$3.01. The company has a quick ratio of 1.08, a current ratio of 2.04 and a debt-to-equity ratio of 14.17. The firm has a market cap of C$58.93 million, a price-to-earnings ratio of 10.80 and a beta of 0.81. BioRem Inc. has a 52 week low of C$1.87 and a 52 week high of C$3.95.
BioRem Company Profile
Read More
- Five stocks we like better than BioRem
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Receive News & Ratings for BioRem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRem and related companies with MarketBeat.com's FREE daily email newsletter.
